Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy

Denggang Fu; Biyu Zhang; Yinghua Zhang; Jueping Feng; Hua Jiang

doi:10.1016/j.gendis.2023.01.022

您当前的位置：

首页 >

文章列表页 >

Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy

Short communication | 更新时间：2024-02-04

- Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy
- Genes & Diseases Vol. 1, Issue 6, Pages: 2274-2277(2023)
- 作者机构：
  
  1. School of Medicine, Indiana University,IN,Indianapolis,United States,46202
  2. School of Chemical Engineering & Pharmacy, Wuhan Institute of Technology,Hubei,Wuhan,China,430205
  3. Wuhan Fourth Hospital,Hubei,Wuhan,China,430033
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.01.022
  CLC：
- Published：2023，
  
  Published Online：1 November 2023，
扫描看全文
Denggang Fu, Biyu Zhang, Yinghua Zhang, et al. Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy. [J]. Genes & Diseases 1(6):2274-2277(2023)
DOI：

Denggang Fu, Biyu Zhang, Yinghua Zhang, et al. Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy. [J]. Genes & Diseases 1(6):2274-2277(2023) DOI： 10.1016/j.gendis.2023.01.022.

摘要

Abstract

关键词

Keywords

references

1 N. Rekhtman, P.K. Paik, M.E. Arcila, et al.Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations Clin Cancer Res, 18 (4) (2012), pp. 1167-1176

2 Y. He, Z. Jiang, C. Chen, et al.Classification of triple-negative breast cancers based on Immunogenomic profiling J Exp Clin Cancer Res, 37 (2018), p. 327

3 N. Karachaliou, M. Gonzalez-Cao, G. Crespo, et al.Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients Ther Adv Med Oncol, 10 (2018), Article 1758834017749748

4 X. Li, S. Ma, Y. Deng, et al.Targeting the RNA m6A modification for cancer immunotherapy Mol Cancer, 21 (2022), p. 76

5 F. Sabbatino, L. Liguori, G. Polcaro, et al.Role of human leukocyte antigen system as a predictive biomarker for checkpoint-based immunotherapy in cancer patients Int J Mol Sci, 21 (19) (2020), p. 7295

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools